Depo-Provera is the brand name for medroxyprogesterone acetate, a contraceptive shot containing the hormone progestin. It works by:

• Suppressing ovulation, preventing the release of eggs from the ovaries.
• Thickening cervical mucus to block sperm from reaching the egg.

Administered as an injection every three months, Depo-Provera offers a convenient birth control option for millions of women. However, its high levels of synthetic progestin have raised concerns about potential long-term risks.

Recent studies, including one published in the British Medical Journal, have linked Depo-Provera to a significantly increased risk of developing meningiomas, particularly with prolonged use. Key findings include:

• Elevated Risk: Women who used Depo-Provera were found to be over five times more likely to develop meningiomas compared to non-users.
• Dose-Response Relationship: The risk increases with the number of injections received over time.

Meningiomas are tumors that develop in the protective membranes surrounding the brain and spinal cord. Symptoms may include:

• Persistent headaches
• Blurred or double vision
• Dizziness or balance issues
• Seizures
• Memory loss or cognitive impairments

If you have experienced any of these symptoms and have a history of Depo-Provera use, it’s important to consult a healthcare provider immediately.

Pfizer, the manufacturer of Depo-Provera, is accused of failing to adequately warn consumers and healthcare providers about the risks of meningiomas associated with the drug. Key allegations include:

• Inadequate Labeling: Pfizer failed to include clear warnings about the meningioma risk on U.S. labels, despite adding warnings in Canada and Europe.
• Negligence: The company allegedly ignored or downplayed safety concerns raised by earlier studies and reports.

The lawsuits against Pfizer are being consolidated into a multidistrict litigation (MDL) rather than a class action. This allows each plaintiff to retain an individual case while benefiting from streamlined pre-trial proceedings. The MDL aims to address:

• The link between Depo-Provera’s high-dose progestin and meningiomas.
• Pfizer’s failure to update warnings despite international regulatory actions.

If you or a loved one has developed a meningioma after using Depo-Provera, you may be entitled to compensation for medical expenses, lost wages, and emotional distress. At McGartland Law Firm, we offer:

• Free Consultations: Discuss your case with our experienced attorneys.
• Comprehensive Support: From gathering medical records to navigating the complexities of litigation, we handle every step.
• No Upfront Costs: You pay nothing unless we win your case.

Time may be limited to file your claim due to statute of limitations laws. Don’t wait to seek the justice you deserve. Contact McGartland Law Firm at (866) 832-9300 to learn more about your legal options.

We are committed to holding pharmaceutical companies accountable for putting profits over safety. Let us fight for you.